Intro to genetic testing Flashcards

1
Q

What are the three categories of DNA diagnostic testing?

A

1) infectious disease testing (e.g. HIV, hep B)- biggest
2) Cancer genetics
3) Molecular genetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is medical management directive or non-directive?

A

Directive. This is predictive molecular genetic testing WITH treatment. Personal decision making is predictive withOUT a treatment in mind (carrier screening)-i.e. for something like huntingtons disease where you can’t do anything about or for assessing pregnancy risks, etc. These are both uses of molecular testing.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does Linkage analysis work?

A

(common in 1980s) This is an INdirect test. Ex. You know a disease is present but can’t find it on a gene and don’t know what the mutation is. In looking at a gene in someone who is affected and someone who is not, you can predict (with relative certainty- not total) whether a fetus is at risk. It will not tell you what the mutation is*, but based on surrounding polymorphisms, you can predict the likelihood of passing it on. Not common anymore and only useful if you are certain about the diagnosis and the gene involved.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the common mechanisms for mutation for CF and BRCA 1 gene?

A

roughly 85-90% in both are point mutations and 10-15% are the result of large deletions

both have low new mutation rates (most mutations already exist in families)

CF-autosomal recessive (on chromosome 7) uses a targeted approach because almost 90% of mutations are caused by the same known mutation (high carrier frequency)

BRCA (autosomal dominant) has high mutation frequency, mutation panels only used in special populations (Ashkenazi Jews), general scanning more common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the major causes of Duchenne muscular dystrophy?

A

(x-linked) 75% large deletions and 25% point mutations; high de novo mutation rate (so targeted approaches aren’t very effective); allelic heterogeneity; 1/3 of men with no family history (simplex) will be new mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the major causes of Huntington disease?

A

TNR expansion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the basis of targeting testing?

A

looking for one or more specific mutated (or susceptible) genes. Can look for mutations as small as 1 bp

can look for:

  • single mutation types (factor V leiden)
  • mutation panels (in a single gene- think CF)
  • gene panels

targeted mutation panels are common in CF (23 mutations is the minimum and test will detect about 85% of mutations- will miss 15%) and in Tay-Sachs (will catch about 98%) and

gene PANELS are common in BRCA testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the major strengths of targeted testing?

A

very high accuracy for specific alleles being assayed, widely available, affordable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the major weaknesses of targeted testing?

A

no information about other potential variants other than what’s on the test panel (in that gene OR in other genes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the basis of gene scanning?

A

a discovery approach. typically follows unsuccessful target testing, and screens a gene (or multiple) to find any point mutation from a consensus sequence of a normal gene (so, for example, in CF this will find the other 15% of mutations). Exons, promoters, splice regions, any intron regions where mutations are known to be found are sequenced but introns are not typically sequenced so you won’t find EVERY mutation (thus it is 98-99% accurate, not 100%)

Useful in disorders where there is extensive allelic heterogeneity and where families are likely to carry “private” mutations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the possible outcomes of gene scanning?

A

positive result- pathogenic mutation detected

negative result- nothing found

variant of uncertain significance (VUS) - mutation that hasn’t been reported before and is hard to interpret (CANNOT make clinical decisions based on this)- presumed not to be pathogenic/clinically significant initially

many benign variants are expected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the strengths of gene scanning?

A

comprehensive; once mutation is identified, other family members can be screened using targeted screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the weaknesses of gene scanning?

A

not all mutations will be detected; interpretations can be difficult and can be difficult on patients when inconclusive results are found; polymorphisms are expected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the ‘ACCE’ framework for genetic testing?

A

Analytic validity- accuracy of test

Clinical validity- ability of test to predict outcome

Clinical utility (most important)- ability of results to be used constructively for the patient/ improve outcome

Ethical, social, and legal issues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is autism genetically tested?

A

large gene (30-100 genes) panels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly